lifestyle.cfxmagazine.com

Author: Novartis Pharma AG

Novartis finalizes US manufacturing and R&D expansion plan with seventh new facility

April 30, 2026
Novartis malaria treatment Coartem® Baby receives WHO prequalification, paving way for greater access for newborns and young infants

April 24, 2026
Novartis announces expansion of community health programs to close gaps in heart disease and cancer care, targeting more than 30 countries by 2030

April 9, 2026
Novartis to build new radioligand therapy site in Denton, Texas, delivering more next‑generation treatments to patients

February 25, 2026
Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

February 11, 2026